{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:40:22Z","timestamp":1793209222518,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["SKLRD-OP-202409"],"award-info":[{"award-number":["SKLRD-OP-202409"]}],"id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009659","name":"Guangzhou Medical University","doi-asserted-by":"publisher","award":["02-412-2302-2122XM"],"award-info":[{"award-number":["02-412-2302-2122XM"]}],"id":[{"id":"10.13039\/100009659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009659","name":"Guangzhou Medical University","doi-asserted-by":"publisher","award":["202201010378"],"award-info":[{"award-number":["202201010378"]}],"id":[{"id":"10.13039\/100009659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009659","name":"Guangzhou Medical University","doi-asserted-by":"publisher","award":["02-410-2302366XM"],"award-info":[{"award-number":["02-410-2302366XM"]}],"id":[{"id":"10.13039\/100009659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013262","name":"State Key Laboratory of Respiratory Disease","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013262","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.canlet.2024.216765","type":"journal-article","created":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T19:00:04Z","timestamp":1708801204000},"page":"216765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Lovastatin\/SN38 co-loaded liposomes amplified ICB therapeutic effect via remodeling the immunologically-cold colon tumor and synergized stimulation of cGAS-STING pathway"],"prefix":"10.1016","volume":"588","author":[{"given":"Yi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiena","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9835-4729","authenticated-orcid":false,"given":"Wenxia","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Inam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanshan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9512-9664","authenticated-orcid":false,"given":"Wenjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2024.216765_bib1","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.canlet.2024.216765_bib2","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.3389\/fimmu.2019.01654","article-title":"Cytotoxic chemotherapy as an immune Stimulus: a molecular perspective on turning up the immunological Heat on cancer","volume":"10","author":"Opzoomer","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2024.216765_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100883","article-title":"Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA","volume":"65","author":"Ye","year":"2022","journal-title":"Drug Resist. Updates : reviews and commentaries in antimicrobial and anticancer chemotherapy"},{"key":"10.1016\/j.canlet.2024.216765_bib4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/DCR.0000000000002323","article-title":"The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of colon cancer","volume":"65","author":"Vogel","year":"2022","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.canlet.2024.216765_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221148540","article-title":"New developments in targeted therapy for metastatic colorectal cancer","volume":"15","author":"Wong","year":"2023","journal-title":"Therapeutic Advances in Medical Oncology"},{"key":"10.1016\/j.canlet.2024.216765_bib6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2024.216765_bib7","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1158\/1078-0432.CCR-20-3635","article-title":"The landscape of alterations in DNA damage response pathways in colorectal cancer","volume":"27","author":"Arai","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.216765_bib8","first-page":"785","article-title":"Metabolic barriers to cancer immunotherapy, Nature reviews","volume":"21","author":"DePeaux","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.canlet.2024.216765_bib9","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2024.216765_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41573-021-00189-2","article-title":"Navigating CAR-T cells through the solid-tumour microenvironment, Nature reviews","volume":"20","author":"Hou","year":"2021","journal-title":"Drug discovery"},{"key":"10.1016\/j.canlet.2024.216765_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41565-020-00822-y","article-title":"Nanomaterials for T-cell cancer immunotherapy","volume":"16","author":"Gong","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.canlet.2024.216765_bib12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41574-020-0398-9","article-title":"Immunotherapy for advanced thyroid cancers - rationale, current advances and future strategies","volume":"16","author":"French","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.canlet.2024.216765_bib13","first-page":"345","article-title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors, Nature reviews","volume":"18","author":"Doroshow","year":"2021","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.canlet.2024.216765_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.immuni.2018.03.007","article-title":"Combination cancer therapy with immune checkpoint blockade: mechanisms and strategies","volume":"48","author":"Patel","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2024.216765_bib15","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nri3921","article-title":"STING: infection, inflammation and cancer","volume":"15","author":"Barber","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2024.216765_bib16","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.canlet.2024.216765_bib17","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1080\/13543776.2022.2144220","article-title":"Recent advances in the development of STING inhibitors: an updated patent review","volume":"32","author":"Shen","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.canlet.2024.216765_bib18","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.abc6622","article-title":"Immunotherapy with a sting","volume":"369","author":"Gajewski","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.canlet.2024.216765_bib19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41392-022-01252-z","article-title":"Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2024.216765_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-00916-z","article-title":"cGAS-STING, an important pathway in cancer immunotherapy","volume":"13","author":"Jiang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2024.216765_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aax7942","article-title":"The cytosolic DNA sensor cGAS recognizes neutrophil extracellular traps","volume":"14","author":"Apel","year":"2021","journal-title":"Sci. Signal."},{"key":"10.1016\/j.canlet.2024.216765_bib22","first-page":"1452","article-title":"The cGAS\u2013STING pathway and cancer","volume":"3","author":"Samson","year":"2022","journal-title":"Nat. Can. (Ott.)"},{"key":"10.1016\/j.canlet.2024.216765_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaz2738","article-title":"NK cells mediate clearance of CD8(+) T cell-resistant tumors in response to STING agonists","volume":"5","author":"Nicolai","year":"2020","journal-title":"Science immunology"},{"key":"10.1016\/j.canlet.2024.216765_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay9013","article-title":"cGAS-STING-mediated DNA sensing maintains CD8(+) T cell stemness and promotes antitumor T cell therapy","volume":"12","author":"Li","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2024.216765_bib25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41565-018-0342-5","article-title":"Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy","volume":"14","author":"Shae","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.canlet.2024.216765_bib26","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1038\/s41388-018-0581-9","article-title":"Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles","volume":"38","author":"Grabosch","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2024.216765_bib27","series-title":"Topoisomerase 1 Inhibition Promotes Cyclic GMP-AMP Synthase-dependent Antiviral Responses","first-page":"8","author":"P\u00e9pin","year":"2017"},{"key":"10.1016\/j.canlet.2024.216765_bib28","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1172\/JCI127471","article-title":"cGAS\/STING axis mediates a topoisomerase II inhibitor\u2013induced tumor immunogenicity","volume":"129","author":"Wang","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2024.216765_bib29","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.apsb.2021.03.043","article-title":"DNA damage repair promotion in colonic epithelial cells by andrographolide downregulated cGAS\u2012STING pathway activation and contributed to the relief of CPT-11-induced intestinal mucositis","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.canlet.2024.216765_bib30","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1158\/1078-0432.CCR-19-1089","article-title":"Targeting topoisomerase I in the era of precision medicine","volume":"25","author":"Thomas","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.216765_bib31","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00018-019-03299-8","article-title":"Targeting DNA repair in cancer: current state and novel approaches","volume":"77","author":"Klinakis","year":"2020","journal-title":"Cell. Mol. Life Sci. : CM"},{"key":"10.1016\/j.canlet.2024.216765_bib32","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1158\/2159-8290.CD-18-1218","article-title":"PARP inhibitor efficacy Depends on CD8(+) T-cell Recruitment via intratumoral STING pathway activation in BRCA-Deficient models of Triple-Negative breast cancer","volume":"9","author":"Pantelidou","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2024.216765_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120542","article-title":"In situ activation of STING pathway with polymeric SN38 for cancer chemoimmunotherapy","volume":"268","author":"Zhao","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2024.216765_bib34","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106065","article-title":"5\u2010Fluorouracil efficacy requires anti\u2010tumor immunity triggered by cancer\u2010cell\u2010intrinsic STING","volume":"40","author":"Tian","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2024.216765_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001361","article-title":"Integrated analysis of concomitant medications and oncological outcomes from PD-1\/PD-L1 checkpoint inhibitors in clinical practice","volume":"8","author":"Cortellini","year":"2020","journal-title":"Journal for immunotherapy of cancer"},{"key":"10.1016\/j.canlet.2024.216765_bib36","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hed.26036","article-title":"Impact of PD\u2010L1 expression and human papillomavirus status in anti\u2010PD1\/PDL1 immunotherapy for head and neck squamous cell carcinoma\u2014systematic review and meta\u2010analysis","volume":"42","author":"Patel","year":"2020","journal-title":"Head Neck"},{"key":"10.1016\/j.canlet.2024.216765_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161940","article-title":"Statin shapes inflamed tumor microenvironment and enhances immune checkpoint blockade in non\u2013small cell lung cancer","volume":"7","author":"Mao","year":"2022","journal-title":"JCI insight"},{"key":"10.1016\/j.canlet.2024.216765_bib38","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41391-022-00554-1","article-title":"Statins and prostate cancer-hype or hope? The epidemiological perspective","volume":"25","author":"Craig","year":"2022","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.canlet.2024.216765_bib39","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1158\/1078-0432.CCR-20-1967","article-title":"Statins as anticancer agents in the era of precision medicine","volume":"26","author":"Longo","year":"2020","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.canlet.2024.216765_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4938539","article-title":"Statins are associated with improved survival of patients with Gastric cancer: a systematic review and meta-analysis","volume":"2022","author":"Yuan","year":"2022","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.canlet.2024.216765_bib41","first-page":"610","article-title":"The multifaceted roles of PARP1 in DNA repair and chromatin remodelling, Nature reviews","volume":"18","author":"Ray Chaudhuri","year":"2017","journal-title":"Molecular cell biology"},{"key":"10.1016\/j.canlet.2024.216765_bib42","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1073\/pnas.1508535113","article-title":"Gain-of-function mutations of Ptpn11 (Shp2) cause aberrant mitosis and increase susceptibility to DNA damage-induced malignancies","volume":"113","author":"Liu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2024.216765_bib43","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1158\/0008-5472.CAN-20-3738","article-title":"SHP2-mediated inhibition of DNA repair contributes to cGAS\u2013STING activation and chemotherapeutic sensitivity in colon cancer","volume":"81","author":"Wei","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.216765_bib44","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","article-title":"Targeting the DNA damage response in cancer","volume":"60","author":"O'Connor","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2024.216765_bib45","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.tips.2022.08.006","article-title":"Nanodelivery of cGAS-STING activators for tumor immunotherapy","volume":"43","author":"Guo","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2024.216765_bib46","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1158\/1078-0432.CCR-18-1932","article-title":"Tumor microenvironment remodeling by intratumoral oncolytic vaccinia virus enhances the efficacy of immune-checkpoint blockade","volume":"25","author":"Chon","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.216765_bib47","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41467-020-17670-y","article-title":"A decade of immune-checkpoint inhibitors in cancer therapy","volume":"11","author":"Robert","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.216765_bib48","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.celrep.2015.03.069","article-title":"DNA-damage-induced type I interferon promotes senescence and inhibits stem cell function","volume":"11","author":"Yu","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2024.216765_bib49","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1126\/science.1249361","article-title":"Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis","volume":"343","author":"Newton","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.canlet.2024.216765_bib50","doi-asserted-by":"crossref","first-page":"e1334","DOI":"10.1002\/ctm2.1334","article-title":"RIPK3-MLKL necroptotic signalling amplifies STING pathway and exacerbates lethal sepsis","volume":"13","author":"Zhang","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.canlet.2024.216765_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf6290","article-title":"ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation","volume":"7","author":"Yang","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2024.216765_bib52","article-title":"Metronomic chemotherapy as a potential partner of immune checkpoint inhibitors for metastatic colorectal cancer treatment","author":"Hong","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216765_bib53","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.canlet.2020.05.027","article-title":"Mithramycin suppresses DNA damage repair via targeting androgen receptor in prostate cancer","volume":"488","author":"Wang","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216765_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.03.026","article-title":"Proton pump inhibitors suppress DNA damage repair and sensitize treatment resistance in breast cancer by targeting fatty acid synthase","volume":"509","author":"Wang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216765_bib55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2011.12.025","article-title":"Use of the \u03b3-H2AX assay to monitor DNA damage and repair in translational cancer research","volume":"327","author":"Ivashkevich","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216765_bib56","article-title":"Immune-checkpoint inhibitor resistance in cancer treatment: current progress and future directions","author":"Zhang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216765_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216167","article-title":"Improvement strategy for immune checkpoint blockade: a focus on the combination with immunogenic cell death inducers","author":"Shi","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216765_bib58","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","article-title":"The tumour microenvironment in pancreatic cancer\u2014clinical challenges and opportunities","volume":"17","author":"Ho","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2024.216765_bib59","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ymthe.2021.08.028","article-title":"Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment","volume":"30","author":"Han","year":"2022","journal-title":"Mol. Ther."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524001587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524001587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:05:18Z","timestamp":1777550718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524001587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":59,"alternative-id":["S0304383524001587"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216765","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lovastatin\/SN38 co-loaded liposomes amplified ICB therapeutic effect via remodeling the immunologically-cold colon tumor and synergized stimulation of cGAS-STING pathway","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"216765"}}